BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20957396)

  • 1. Lipid glycation and protein glycation in diabetes and atherosclerosis.
    Miyazawa T; Nakagawa K; Shimasaki S; Nagai R
    Amino Acids; 2012 Apr; 42(4):1163-70. PubMed ID: 20957396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of amadori-glycated phosphatidylethanolamine in the plasma of healthy subjects and diabetic patients by liquid chromatography-tandem mass spectrometry.
    Miyazawa T; Ibusuki D; Yamashita S; Nakagawa K
    Ann N Y Acad Sci; 2008 Apr; 1126():291-4. PubMed ID: 18448834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycation of plasma lipoprotein lipid membrane and screening for lipid glycation inhibitor.
    Nakagawa K; Ibusuki D; Yamashita S; Miyazawa T
    Ann N Y Acad Sci; 2008 Apr; 1126():288-90. PubMed ID: 18448833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of AGEs formation by natural products.
    Nagai R; Shirakawa J; Ohno R; Moroishi N; Nagai M
    Amino Acids; 2014 Feb; 46(2):261-6. PubMed ID: 23504149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats.
    Karachalias N; Babaei-Jadidi R; Kupich C; Ahmed N; Thornalley PJ
    Ann N Y Acad Sci; 2005 Jun; 1043():777-83. PubMed ID: 16037305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally occurring inhibitors against the formation of advanced glycation end-products.
    Peng X; Ma J; Chen F; Wang M
    Food Funct; 2011 Jun; 2(6):289-301. PubMed ID: 21779567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potentials of unicellular green alga Chlorella in advanced glycation end product (AGE)-related disorders.
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(5):953-5. PubMed ID: 15996828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminophospholipid glycation and its inhibitor screening system: a new role of pyridoxal 5'-phosphate as the inhibitor.
    Higuchi O; Nakagawa K; Tsuzuki T; Suzuki T; Oikawa S; Miyazawa T
    J Lipid Res; 2006 May; 47(5):964-74. PubMed ID: 16470027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of blood lipid glycation and lipid oxidation in diabetic patients.
    Suzuki K; Nakagawa K; Miyazawa T
    Clin Chem Lab Med; 2014 Jan; 52(1):47-52. PubMed ID: 23454716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
    Khalifah RG; Baynes JW; Hudson BG
    Biochem Biophys Res Commun; 1999 Apr; 257(2):251-8. PubMed ID: 10198198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients.
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(6):1013-5. PubMed ID: 16146671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
    Yamagishi S; Ueda S; Okuda S
    Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycated proteins in diabetes.
    Furth AJ
    Br J Biomed Sci; 1997 Sep; 54(3):192-200. PubMed ID: 9499597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update.
    Lapolla A; Fedele D; Seraglia R; Traldi P
    Mass Spectrom Rev; 2006; 25(5):775-97. PubMed ID: 16625652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.
    Friedman EA
    Diabetes Care; 1999 Mar; 22 Suppl 2():B65-71. PubMed ID: 10097902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-enzymatic glycation of proteins: a cause for complications in diabetes.
    Nawale RB; Mourya VK; Bhise SB
    Indian J Biochem Biophys; 2006 Dec; 43(6):337-44. PubMed ID: 17285797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose.
    Thornalley PJ; Langborg A; Minhas HS
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):109-16. PubMed ID: 10548540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
    Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
    Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation endproducts and cigarette smoking.
    Nicholl ID; Bucala R
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1025-33. PubMed ID: 9846884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Maillard reaction and its consequences for a living body.
    Sztanke K; Pasternak K
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):159-62. PubMed ID: 15323185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.